The breast cancer treatment, Taxotere, may be more likely to cause permanent alopecia (hair loss) than other chemotherapy drugs. Today, Taxotere is one of the most common chemo drugs administered to breast cancer patients, both those with operable tumors and those with inoperable metastatic disease. It is a highly toxic chemotherapy agent, nearly double the toxicity of its close competitor, Taxol, a drug shown to be every bit as effective as Taxotere.
Taxotere is a chemotherapy agent that is usually administered in conjunction with other cancer drugs. In addition to breast cancer, the medication is indicated to treat head and neck cancer; gastric cancer, prostate cancer and non-small cell lung cancer.
Sanofi-Aventis is facing a growing number of lawsuits accusing the drug-maker of inadequately warning about the risk of permanent baldness. Before the label updates, the drug-maker reassured women that “hair generally grows back” after treatment. One can also navigate to www.taxoterehairlawsuit.com/taxotere-lawsuit-lawyers.aspx if you want to get information related to hairloss Lawsuits.
Hair loss is a well known side effect of chemotherapy, and Taxotere is no exception. Patients undergoing Taxotere treatment were led to believe that alopecia associated with its use would be temporary. However, it now appears that Taxotere may increase the risk of permanent hair loss.
Some of these women have even chosen to file lawsuits against the drug’s manufacturer, a French company called Sanofi, who they say has been hiding evidence of Taxotere’s link to permanent alopecia for years.
Women across the country are beginning to file lawsuits over a chemotherapy drug they say causes permanent hair loss. It’s called Taxotere, and many patients, including the women at Ahead Of Our Time, claim they were never warned of this traumatic side effect.
When Taxotere was finally approved in 1996, the FDA restricted its indications to just one group of patients: people with “locally advanced or metastatic breast cancer after failure of prior chemotherapy.”
When this warning was released, Sanofi promptly put a warning label on the drug, but the damage was already done on numerous breast cancer patients.
Lawsuits are beginning to be filed against the company by affected patients claiming a variety of damages. There have been no large settlements on Taxotere claims to date, but it does not mean that there is no hope. You can also navigate to this website if you want to get information related to hairloss lawsuits.
It is still a relatively new topic and many lawsuits are actively pending following extensive discovery into scientific research and information affirmatively linking Taxotere to the permanent hair loss suffered by so many patients. As more research is uncovered and a clear link is established, more and more patients will likely have a claim against Sanofi.
Taxotere can have serious consequences on a cancer patient. It could affect them emotionally and financially as well. If not for the drug, the patient would still have been earning much for their family. The good news is that there is still hope and those who have suffered may be able to recover damages and make the responsible parties liable for what they have done.